Robuta

https://iris.unisr.it/handle/20.500.11768/134898 Lessons and open questions in borderline resectable pancreatic cancer open questionslessonsborderlineresectablepancreatic https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2023-10668&r=1 Pembrolizumab + N-803 Alone or in Combination With PD-L1 t-haNK Cells for Resectable Head and Neck... Pembrolizumab + N-803 Alone or in Combination With PD-L1 t-haNK Cells for Resectable Head and Neck Squamous Cell Carcinoma https://mider.openrepository.com/entities/publication/1f1ad0c0-85b8-4082-9b03-d7a066ba7044 Intranetwork variation in neoadjuvant therapy delivery for borderline resectable and locally... Introduction: Pancreatic cancer (PC) treatment in the UK is coordinated via regional referral networks, but formal neoadjuvant chemotherapy (NAC) pathways for... variationtherapy https://www.knowcancer.com/cancer-trials/NCT01035385/ Compare FOFLOX4 in Preoperative and Postoperative and Postoperative in Resectable Liver Metastasis... This study is a multicenter, open-label, randomized ,controlled phase III study to compare preoperative and postoperative with FOFLOX4 chemotherapy and comparepreoperativepostoperativeresectableliver https://pubmed.ncbi.nlm.nih.gov/16129366/?dopt=Abstract Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus:... Preoperative chemoradiotherapy with cisplatin and fluorouracil does not significantly improve progression-free or overall survival for patients with resectable... followed by https://blog.medfriendly.com/2013/02/liver-transplants-increase-survival.html?m=0 MedFriendly Medical Blog: Liver Transplants Increase Survival Rate for Non-Resectable Colorectal... Breaking medical news, commentary, and perspectives on diverse healthcare topics, particularly those that are interesting or unusual. medfriendly medical blogliver transplants https://www.cancernetwork.com/view/available-treatment-options-for-patients-with-stage-iii-resectable-nsclc Available Treatment Options for Patients With Stage-III Resectable NSCLC | CancerNetwork May 19, 2026 - Alykhan Nagji, MD, provides a brief overview of the landscape surrounding the treatment of patients with stage-III resectable NSCLC. treatment optionsfor patientsstage iiiavailable https://app.quri.ai/trials/NCT07565857/signatera-guided-de-escalation-of-adjuvant-therapy-in-resect Signatera-Guided De-escalation of Adjuvant Therapy in Resectable Stage II-IVa... Connect with this clinical trial through Quri.ai's free matching service. Signatera-Guided De-escalation of Adjuvant Therapy in Resectable Stage II-IVa... adjuvant therapy https://unige.iris.cineca.it/handle/11567/183515 Adjuvant systemic treatment of resectable breast cancer: eleven years results of a... systemic treatmentbreast cancereleven yearsadjuvantresectable https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2022-01113 Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer - NCI Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer non small cell lung canceradjuvant treatment https://iris.unisr.it/handle/20.500.11768/132354 The Effect of a Liver Transplant Program on the Outcomes of Resectable Hepatocellular Carcinoma: A... liver transplant programthe effect https://www.sciencerepository.org/abstract?doi=10.31487/j.ACO.2021.02.03 Abstract High-Percentage of Early Resectable Pancreatic Ductal Adenocarcinoma is Unidentified on... Objective: Pancreatic ductal adenocarcinoma (PDAC) has the best survival when detected early with 5-year survival near 40% for small, resectable PDAC. We... percentage of https://pure.skku.edu/en/publications/comparison-of-initial-treatments-for-resectable-hepatocellular-ca/ Comparison of initial treatments for resectable hepatocellular carcinoma within Milan criteria: an... https://adisinsight.springer.com/trials/700322866?error=cookies_not_supported&code=b4227553-8348-4eac-ae31-39ed4d35c410 A Phase I Study of Nivolumab and Intratumoral BO 112 for Resectable Soft Tissue Sarcoma -... This phase I trial studies the side effects of BO-112 when given together with nivolumab before surgery in treating patients with soft tissue sarcoma that can https://deceraclinical.com/education/activities/oncology/io-in-resectable-nsclc/43307/content Applying Evidence for Immunotherapy in Resectable Nonmetastatic NSCLC | Decera Clinical Education Download this slideset for an overview of data on immunotherapy in the setting of resectable nonmetastatic NSCLC. applyingevidenceimmunotherapy